SEARCH

SEARCH BY CITATION

References

  • 1
    World Health Organization (WHO). WHO Model List of Essential Medicines—18th List. Geneva, Switzerland: World Health Organization; 2013.
  • 2
    Balhara Y. P. S., Mathur S. Alcohol: a major public health problem—South Asian perspective. Addict Disord Their Treat 2012; 11: 101120.
  • 3
    World Health Organization (WHO). The Global Burden of Disease: 2004 Update. Geneva, Switzerland: World Health Organization; 2008.
  • 4
    World Health Organization (WHO). Global Status Report on Alcohol and Health. Geneva, Switzerland: World Health Organization; 2011.
  • 5
    Lustman P. J., Griffith L. S., Clouse R. E. Depression in adults with diabetes. Semin Clin Neuropsychiatry 1997; 2: 1523.
  • 6
    World Health Organization (WHO). Executive Summary—WHO Model List of Essential Medicines, 18th List. Geneva, Switzerland: World Health Organization; 2013.
  • 7
    World Health Organization (WHO). WHO Model List of Essential Medicines—14th List. Geneva, Switzerland: World Health Organization; 2005.
  • 8
    World Health Organization (WHO). WHO Model List of Essential Medicines—17th List. Geneva, Switzerland: World Health Organization; 2011.
  • 9
    World Health Organization (WHO). WHO Model List of Essential Medicines—16th List. Geneva, Switzerland: World Health Organization; 2010.
  • 10
    World Health Organization (WHO). WHO Model List of Essential Medicines—15th List. Geneva, Switzerland: World Health Organization; 2007.
  • 11
    Ntais C., Pakos E., Kyzas P., Ioannidis J. P. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev 2005; (3): CD005063.
  • 12
    Rosner S., Hackl-Herrwerth A., Leucht S., Vecchi S., Srisurapanont M., Soyka M. Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev 2010; (12): CD001867.
  • 13
    Rosner S., Hackl-Herrwerth A., Leucht S., Lehert P., Vecchi S., Soyka M. Acamprosate for alcohol dependence. Cochrane Database Syst Rev 2010; (9): CD004332.
  • 14
    Palmer A. J., Neeser K., Weiss C., Brandt A., Comte S., Fox M. The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acamprosate. Alcohol Alcohol 2000; 35: 478492.
  • 15
    Zarkin G. A., Bray J. W., Aldridge A., Mitra D., Mills M. J., Couper D. J. et al. Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients. Arch Gen Psychiatry 2008; 65: 12141221.